title: Conditional inactivation of the dopamine receptor 5 gene: flanking the Drd5 gene with loxP sites.
authors.affiliation: Memory Pharmaceuticals Corp., Montvale, New Jersey 07645, USA. heyer@memorypharma.com
authors.forename: Joerg
authors.initials: J
authors.lastname: Heyer
authors.forename: Qiurong
authors.initials: Q
authors.lastname: Xiao
authors.forename: Bozena
authors.initials: B
authors.lastname: Bugaj-Gaweda
authors.forename: Sylvie
authors.initials: S
authors.lastname: Ramboz
authors.forename: Axel
authors.initials: A
authors.lastname: Unterbeck
mesh_terms: D000818:Animals; D004926:Escherichia coli; D005786:Gene Expression Regulation; D020868:Gene Silencing; D019426:Integrases / Q000235:genetics; D051379:Mice; D017447:Receptors, Dopamine D1 / Q000235:genetics*; D050641:Receptors, Dopamine D5; D014764:Viral Proteins / Q000235:genetics
chemical_list: C493606:Drd5 protein, mouse; D017447:Receptors, Dopamine D1; D014764:Viral Proteins; D050641:Receptors, Dopamine D5; C045073:Cre recombinase; D019426:Integrases